Ash, United Kingdom

John C Danielewicz

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John C Danielewicz. Retrieved from https://idiyas.com/inventor/john-c-danielewicz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of John C Danielewicz

Introduction: John C Danielewicz, a prominent inventor based in Ash, England, has made significant contributions to the field of pharmaceutical innovations. With a focus on novel compounds, Danielewicz holds a patent that delves into the development of antihypertensive agents.

Latest Patents: Danielewicz's notable patent is centered on (2-Imidazolin-2-ylamino) substituted quinoxalines and quinazolines. This inventive work outlines the preparation and applications of these compounds in treating hypertension, showcasing the potential for breakthroughs in medical treatment.

Career Highlights: Currently associated with Pfizer Corporation, John C Danielewicz has established himself in the pharmaceutical industry through his innovative research and development efforts. His work emphasizes the importance of new antihypertensive agents in improving patient outcomes.

Collaborations: Throughout his career, Danielewicz has collaborated with notable colleagues, including Michael Snarey and Geoffrey N Thomas. These partnerships reflect a commitment to teamwork in advancing medical science and developing effective therapeutic solutions.

Conclusion: John C Danielewicz exemplifies the essence of innovation in the pharmaceutical sector. His patent contributions are a testament to his dedication and expertise in developing potentially life-saving medications, making him a valuable figure in the realm of healthcare advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…